21 /100
LOW RISK
Score updated May 30, 2026

RAPP — Rapport Therapeutics, Inc. Dilution Risk Tracker

Track RAPP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RAPP — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for RAPP.
🔔 Track RAPP — Get forecast alerts →

💹 Market Data

Market Cap$1.89B
Shares Outstanding47.83M
Float31.75M
Cash$476.78M
Debt$10.80M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 3.3% shares (2025Q4 vs prior)
144 institutional holders · 51.62M shares
#1 TRV GP V, LLC 7.14M shares
#2 FMR LLC 7.11M shares
#3 ARCH Venture Management, LLC 3.73M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.42M
Days to Cover6.9
% of Float7.6%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Mar 31, 2026
4 INSIDER TRANSACTION Mar 26, 2026
4 INSIDER TRANSACTION Mar 09, 2026
4 INSIDER TRANSACTION Feb 19, 2026
4 INSIDER TRANSACTION Feb 04, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track RAPP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RAPP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADT
🔬 More Research for RAPP
📊 RAPP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 RAPP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.